Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD of Tengjun Biotechnology Corp. from 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Tengjun Biotechnology Corp. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and change rate from 2020 to Q2 2023.
  • Tengjun Biotechnology Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending 30 Jun 2023 was -$2.46M, a 163% decline year-over-year.
  • Tengjun Biotechnology Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending 30 Jun 2023 was $5.04M, a 35.9% increase year-over-year.
  • Tengjun Biotechnology Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $11.1M.
  • Tengjun Biotechnology Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$784K, a 3.26% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Change (%)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Change (%)

Tengjun Biotechnology Corp. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $5.04M -$2.46M -$6.33M -163% 01 Apr 2023 30 Jun 2023 10-Q 15 Aug 2023
Q1 2023 $11.4M $484K +$274K +131% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $11.1M $4.01M +$4.28M 01 Oct 2022 31 Dec 2022 10-K 17 Apr 2023
Q3 2022 $6.81M $3M +$3.11M 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $3.7M $3.88M +$4.12M 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2023
Q1 2022 -$414K $210K +$369K 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$784K -$271K 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 -$111K 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$242K 01 Apr 2021 30 Jun 2021 10-Q/A 16 Sep 2022
Q1 2021 -$160K 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022

Tengjun Biotechnology Corp. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $11.1M +$11.9M 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 -$784K -$24.7K -3.26% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 -$759K 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.